Abstract A delayed model describing the dynamics of HIV (Human Immunodeficiency Virus) with CTL (Cytotoxic T Lymphocytes) immune response is investigated. The model includes four nonlinear differential equations describing the evolution of uninfected, infected, free HIV viruses, and CTL immune response cells. It includes also intracellular delay and two treatments (two controls). While the aim of first treatment consists to block the viral proliferation, the role of the second is to prevent new infections. Firstly, we prove the well-posedness of the problem by establishing some positivity and boundedness results. Next, we give some conditions that insure the local asymptotic stability of the endemic and disease-free equilibria. Finally, an optimal control problem, associated with the intracellular delayed HIV model with CTL immune response, is posed and investigated. The problem is shown to have an unique solution, which is characterized via Pontryagin's minimum principle for problems with delays. Numerical simulations are performed, confirming stability of the disease-free and endemic equilibria and illustrating the effectiveness of the two incorporated treatments via optimal control.
we refer the reader to [6, 21] and references therein. Here we observe that, often, models introduce the effect of cellular immune response, also called the cytotoxic T-lymphocyte (CTL) response, which attacks and kills the infected cells [17] . It has been shown that this cellular immune response can control the load of HIV viruses [5, 22] . In [4] , it is assumed that CTL proliferation depends, besides infected cells, as usual, also on healthy cells. Moreover, an optimal control problem associated with the suggested model is studied [4] . Recently, the same problem was tackled by introducing time delays [17] . Here, we continue the investigation of such kind of problems by introducing the HIV virus dynamics to the system of equations. This is important because uninfected cells must be in contact with the HIV virus before they become infected. The proposed basic model, illustrating this type of scenario, is as follows: 
(t)v(t), dy(t) dt = β x(t)v(t) − ay(t) − py(t)z(t), dv(t) dt = aNy(t) − µv(t), dz(t) dt = cx(t)y(t)z(t) − hz(t),

(t), y(t), v(t) and z(t) denote, respectively, the concentrations at time t of uninfected cells, infected cells, HIV virus, and CTL cells. The healthy CD4
+ cells grow at a rate λ , decay at a rate dx(t) and become infected by the virus at a rate β x(t)v(t). Infected cells (y) die at a rate a and are killed by the CTL response at a rate p. Free virus (v) is produced by the infected cells at a rate aN and decay at a rate µ, where N is the number of free virus produced by each actively infected cell during its life time. Finally, CTLs (z) expand in response to viral antigen derived from infected cells at a rate c and decay in the absence of antigenic stimulation at a rate h.
The paper is organized as follows. Section 2 is devoted to the proof of existence, positivity and boundedness of solutions. Then, in Section 3, we do an optimization analysis of the viral infection model. In Section 4, we construct an appropriate numerical algorithm and give some simulations. Finally, conclusions are given in Section 5.
Analysis of the model with delay
In order to be realistic, let us introduce an intracellular time delay to the system of equations (1) . Then, the model takes the following form:
(t)v(t), y(t) = β x(t − τ)v(t − τ) − ay(t) − py(t)z(t), v(t) = aNy(t) − µv(t), z(t) = cx(t)y(t)z(t) − hz(t).
(2)
Here, the delay τ represents the time needed for infected cells to produce virions after viral entry. Model (2) is a system of delayed ordinary differential equations. For such kind of problems, initial functions need to be addressed and an appropriate functional framework needs to be specified. Let us first consider X = C([−τ, 0]; R 4 ) to be the Banach space of continuous mappings from [−τ, 0] to R 4 equipped with the sup-norm ϕ = sup −τ≤t≤0 |ϕ(t)|. We assume that the initial functions verify
Also, from biological reasons, these initial functions x(θ ), y(θ ), v(θ ) and z(θ ) have to be nonnegative:
Positivity and boundedness of solutions
For the solutions of (2) with initial functions satisfying conditions (3) and (4), the following theorem holds. (3) and (4), the system (2) has a unique solution. In addition, the solution is nonnegative and bounded for all t ≥ 0.
Theorem 1 For any initial conditions (x(t), y(t), v(t), z(t)) satisfying
Proof By the standard functional framework of ordinary differential equations (see, for instance, [9] and references therein), we know that there is a unique local solution (x(t), y(t), v(t), z(t)) to system (2) in [0,t m ). From system (2), we have the following:
and
This shows the positivity of solutions in t ∈ [0,t m ). Next, for the boundedness of the solutions, we consider the following function:
This leads to
from which we have
If we set ρ = min d, a 2 , µ , then we have
This proves, via Gronwall's lemma, that F(t) is bounded, and so are the functions x(t), y(t) and v(t). Now, we prove the boundedness of z(t). From the last equation of (2), we havė
z(t) + hz(t) = cx(t)y(t)z(t).
Moreover, from the second equation of (2), it follows thaṫ
Thus, by integrating over time, we have
From the boundedness of x, y and v, and by using integration by parts, it follows the boundedness of z(t). Therefore, every local solution can be prolonged up to any time t m > 0, which means that the solution exists globally.
The linearized problem around the steady-state solution
It is straightforward to establish that model (2) has one disease-free equilibrium given by
and two endemic equilibrium points given as follows:
Consider now the following transformation:
where (x,ȳ,v,z) denotes any equilibrium point E f , E 1 or E 2 . The linearized system of the previous model (2) is of form
System (5) can be written in matrix form as follows:
where A 1 and A 2 are the two matrices given by
Stability of the disease-free equilibrium
We begin by studying the stability of the disease-free equilibrium E f . The following result holds. 
Thus, at the disease-free equilibrium, the characteristic equation takes the form
If we assume τ = 0, then equation (7) becomes
The four roots of (8) are:
It is clear that ζ 1 , ζ 2 and ζ 3 have negative real parts, while ζ 4 has negative real part if Nβ λ − dµ < 0. Suppose that τ > 0. To prove the stability of E f , we use Rouché's theorem. For that, we need to prove that the roots of the characteristic equation (7) cannot have pure imaginary roots, that is, cannot cross the imaginary axis. Suppose the contrary. Let ζ = ωi with ω > 0 a purely imaginary root of (7). Then,
dµ e −iωτ = 0. By using Euler's formula e −iωτ = cos(ωτ) − i sin(ωτ) and by separating the real imaginary parts, we have
Adding the squares in the two equations, one obtains
Let X = ω 2 . We have
which has no positive solution when Nβ λ − dµ < 0. Therefore, there is no root ζ = iω with ω ≥ 0 for (7), implying that the root of (7) cannot intersect the pure imaginary axis. Therefore, all roots of (7) have negative real parts Nβ λ − dµ < 0 and the disease-free equilibrium, E f , is locally asymptotically stable if Nβ λ − dµ < 0. In addition, it is easy to show that (7) has a real positive root when Nβ λ − dµ > 0. Indeed, let us put
Consequently, f has a positive real root and the disease-free equilibrium is unstable.
Stability of the endemic equilibria
We start by studying the local stability of the infected-equilibrium E 1 for any time delay τ.
Theorem 3
The local stability of the disease-free equilibrium E 1 depends on the value of
Precisely, we have: Proof Let λ β N − dµ > 0 and µcλ − β haN > 0. The characteristic equation (6) at E 1 is given by
where
Note that
is a solution of (9) . (10) is a real negative root of the characteristic equation (9), and we just need to analyze equation
Consider now τ = 0. From equation (11), we have
Because β Nλ − dµ > 0, from the Routh-Hurwitz stability criterion, it follows that all roots of (12) have negative real part. Thus, E 1 is locally asymptotically stable for τ = 0. Let τ > 0. Suppose that (9) has pure imaginary roots ζ = ωi with ω > 0. If we replace ζ in (11) by ζ = ωi, and separate the real and imaginary parts, then we obtain −Aω
By adding up the squares of the two equations, and by using the fundamental trigonometric formula, we obtain that (11) has no positive solution because λ β N − dµ > 0. Therefore, there is no root ζ = ωi with ω > 0 for (11) , implying that the root of (11) cannot cross the purely imaginary axis. Thus, all roots of (9) have negative real parts. Then, E 1 is locally asymptotically stable when β N(µcλ − β haN) − µ 2 cd < 0.
For the second endemic equilibrium point E 2 , the following result holds.
The characteristic equation (6) at E 2 is given by
If τ = 0, then the characteristic equation (13) becomes
Let τ > 0. Suppose that (13) has pure imaginary roots ζ = ωi. Replacing ζ in (13) by ωi, and separating the real and imaginary parts, we obtain that
By adding up the squares of both equations, and using the fundamental trigonometric formula, we obtain that
Equation (14) admits at least two pure imaginary roots. Indeed, let λ = 1, d = (14) 
Optimal control
In this section, we study an optimal control problem associated with the delayed HIV model with CTL immune response (2).
The optimization problem
We suggest the following delayed control system with two control variables u 1 and u 2 :
where the controls belong to the control set U defined by
Here, u 1 represents the efficiency of drug therapy in blocking new infections, so that the infection rate in presence of drug is (1 − u 1 ); while u 2 stands for the efficiency of drug therapy in inhibiting viral production, such that the virion production rate under therapy is (1−u 2 ). The optimization problem under consideration is to maximize the objective functional
where t f is the time period of treatment and the positive constants A 1 and A 2 stand for the benefits and costs of the introduced treatment, subject to the control system (15). The two control functions, u 1 (·) and u 2 (·), are assumed to be bounded and Lebesgue integrable. Summarizing, the optimal control problem under study consists to find u * 1 and u * 2 such that
Pontryagin's minimum principle [8] provides necessary optimality conditions for such optimal control problem with delays. Roughly speaking, this principle reduces (17) to a problem of maximizing an Hamiltonian H pointwisely with respect to u 1 and u 2 . In our case the Hamiltonian is given by
By applying Pontryagin's minimum principle [8] , we obtain the following result. 
Theorem 5 For any initial conditions (3)-(4), the system (15) has a unique solution. This solution is nonnegative and bounded for all t ≥ 0. In addition, if u
with transversality conditions
Moreover, the optimal controls satisfy u * 1 (t) = min 1, max 0,
Proof The proof of positivity and boundedness of solutions is similar to the one of Theorem 1. It is enough to use the fact that u i (t) ∈ U, i = 1, 2, which means that u i (t) L ∞ ≤ 1. For the rest of the proof, we remark that the adjoint equations and transversality conditions are obtained by using the Pontryagin minimum principle with delays of [8] , from which
From the optimality conditions,
that is,
Taking into account the bounds in U for the two controls, one obtains u * 1 and u * 2 in form (18).
Existence of an optimal control pair
The existence of the optimal control pair can be directly obtained using the results in [7, 12] . More precisely, we have the following theorem.
Theorem 6
There exists an optimal control pair (u * 1 , u * 2 ) ∈ U solution of (17) .
Proof To use the existence result in [7] , we first need to check the following properties:
(P 1 ) the set of controls and corresponding state variables is nonempty; (P 2 ) the control set U is convex and closed; (P 3 ) the right-hand side of the state system is bounded by a linear function in the state and control variables; (P 4 ) the integrand of the objective functional is concave on U; (P 5 ) there exist constants c 1 , c 2 > 0 and β > 1 such that the integrand
of the objective functional (16) satisfies
Using the result in [12] , we obtain existence of solutions of system (15), which gives condition (P 1 ). The control set is convex and closed by definition, which gives condition (P 2 ). Since our state system is bilinear in u 1 and u 2 , the right-hand side of system (15) satisfies condition (P 3 ), using the boundedness of solutions. Note that the integrand of our objective functional is concave. Also, we have the last needed condition:
where c 2 depends on the upper bound on x and z, and c 1 > 0 since A 1 > 0 and A 2 > 0. We conclude that there exists an optimal control pair (u * 1 , u * 2 ) ∈ U such that
subject to (15) , (3) and (4). The proof is complete.
The optimality system
The optimality system consists of the state system coupled with the adjoint equations, the initial conditions, transversality conditions, and the characterization of optimal controls (18) . Precisely, if we substitute the expressions of u * 1 and u * 2 in (15), then we obtain the following optimality system:
Numerical simulations
In order to solve the optimality system given in Section 3.3, we use a numerical scheme based on forward and backward finite difference approximations. Precisely, we implemented Algorithm 1.
Remark 1
In our implementation, we choose the initial functions (3), satisfying (4), as
In our simulations, the following parameters are used:
Such values respect the HIV parameter ranges given in Table 1 . In Figure 1 , we use the two following initial conditions:
Moreover, besides parameters (19), we have chosen N = 750, which means that Nβ λ − dµ = −0.1125 < 0. According to Theorem 2, the disease-free equilibrium E f = (10, 0, 0, 0) is locally asymptotically stable. The plots of Figure 1 confirm this result of local stability for both initial conditions (20) and (21) . In Algorithm 1 Numerical algorithm for the optimal control problem (17)
Step 1:
Step 2:
for i = 0, . . . , n − 1, do:
Step 3:
for i = 1,... ,n, write:
end for. Figure 2 confirms this result numerically: we clearly see the convergence to the equilibrium point E 2 = (8.33, 0.8, 80, 8.333). However, it is interesting to point out that, with control, a significant decrease of the infected cells, free viruses, and CTL cells, is observed (see Figure 2) . The uninfected cells get maximized. It is worth to mention that with control treatment the infection dies very fast and the dynamics goes toward the disease-free equilibrium. The behavior of the two treatments during time is given in Figure 3 . We can see that the first control makes several switchings from zero to one and vice versa. We can understand from this that one can manage the first treatment to the patient periodically in full manner. In this figure, we can also see that the second control is almost equal to one but with sudden decreases, for some short periods of time, without vanishing.
Conclusion
In this work we have studied a delayed HIV viral infection model with CTL immune response. The considered model includes four differential equations describing the interaction between the uninfected cells, infected cells, HIV free viruses and CTL immune response. An intracellular time delay and two treatments are incorporated to the suggested model. First, existence, positivity and boundedness of solutions are established. Next, an optimization problem is formulated in order to search the better optimal control pair to maximize the number of uninfected cells, reduce the infected cells and minimize the viral load. Two control functions are incorporated in the model, which represent the efficiency of drug treatment in inhibiting viral production and preventing new infections. The existence of such optimal control pair is established and the optimality system is given and solved numerically, using a forward and backward difference approximation scheme. It was shown that the obtained optimal control pair increases considerably the number of CD4+ cells while reducing the number of infected. Moreover, it was also observed that, under optimal control, the viral load decreases significantly compared with the model without control, which will improve the life quality of the patient. It remains an open question how to prove stability of the endemic equilibrium E 2 of model (2) for an arbitrary intracellular time delay τ > 0. The two extremal controls u * 1 and u * 2 for the delayed optimal control problem (17) with N = 1500, parameter values (19) , and initial conditions (20) , obtained using Algorithm 1.
